Others
- Actin(12)
- Adenylate cyclase(27)
- AhR(15)
- Aldose reductase(24)
- Arginase(14)
- AT Receptors(1)
- Autotaxin(4)
- ATP citrate lyase (10)
- BCRP(14)
- Caged Compounds(3)
- ROR/RAR/RXR(95)
- Calmodulin protein kinase II(1)
- CaM kinase II(10)
- Carbonic Anhydrase(54)
- Cell Penetrating Peptide(2)
- Ceramidases(4)
- CERK(1)
- Collagen proline hydroxylase(2)
- COT/TpI2(2)
- COMT(12)
- CPA(1)
- CPG2(1)
- Cytokine(4)
- dCTP Pyrophosphatase(1)
- DHODH(1)
- Diacylglycerol Kinase(1)
- DNA Stain(31)
- eIF2a(2)
- Endopeptidase(3)
- Enzyme Substrates / Activators(70)
- ES-FLI1/RHA(2)
- Farnesyl Diphosphate Synthase(1)
- FBPase(4)
- FLAP(12)
- Fluorescent Probes(344)
- GLI(3)
- Glycoprotein(5)
- Saccharides and Glycosides(13)
- Glyoxalase I(1)
- GSNOR(2)
- GSTP1-1(1)
- Guanylate Cyclase (29)
- Guanylyl Cyclase(7)
- Gutathione S-transferase(13)
- Heme oxygenase(8)
- Hexokinase(4)
- Hydroxylases(10)
- IL Receptor(1)
- Imidazoline Receptors(18)
- IMPDH(1)
- Inositol Phosphatases(4)
- Lp-PLA2(1)
- LpxC(1)
- Matrix Metalloprotease(1)
- MDR multidrug resistance(47)
- Menin-MLL(5)
- MGMT(2)
- Mineralocorticoid Receptor(20)
- Miscellaneous Compounds(9)
- MyD88(7)
- Myosin(24)
- NAE(2)
- NADPH Oxidase(14)
- Nampt(23)
- Natriuretic Peptide Receptors(4)
- Nitric Oxide(85)
- Nuclear Receptors(13)
- Oxygenases/Oxidases(5)
- PDHK(10)
- PGC-1α(2)
- Pregnane X Receptors(2)
- Reductases(7)
- Renin(12)
- Retinoid X Receptors(11)
- Squalene epoxidase(5)
- SGK(13)
- sFRP-1(1)
- SPHK(19)
- Synthases/Synthetases(12)
- Tachykinin(6)
- Thrombopoietin Receptor(7)
- Thymidine phosphorylase(4)
- Transcription Factors(117)
- Transketolase(4)
- β(1,3)-D-Glucan Synthase(2)
- β-Lactamase(3)
- XAO(4)
- Others(2512)
- BMI-1(1)
- Hydrogen Peroxide
- Ascorbic Acid
- SOD(3)
- Homodimerizers(2)
- Renal Diseases(9)
- PAF-AH(1)
- FAS(26)
- calmodulin(3)
- Protein synthesis(5)
- Epac(1)
- MAGL(20)
- exocytosis(1)
- peroxiredoxins(1)
- Glucosidase(47)
- Estrogen Receptor/ERR(171)
- Progesterone Receptor(35)
- Cyclase(6)
- Environmental Toxicology(265)
- Glycerolipid Lipases(15)
- Tec(3)
- Lipases(26)
- Multidrug-Resistance Proteins(8)
- Negative Controls(9)
- Nucleic Acid Turnover/Signaling(73)
- Organ- & System-Specific Toxicity(163)
- Pesticides(119)
- Pharmaceutical Impurities(37)
- Sulfotransferases(4)
- Toxicology(160)
- UDP Glucuronosyltransferases(47)
- Xenobiotic Sensing(27)
- Inhibitory Antibodies(176)
- Amino Acid Derivatives(3)
Others 相关产品(1696)
- GC49389Tritylolmesartan MedoxomilCAS: 144690-92-6纯度: >98.00%
An intermediate in the synthesis of olmesartan medoxomil
- GC49413Rizatriptan N-oxideCAS: 260435-42-5纯度: >90.00%
A potential impurity found in commercial preparations of rizatriptan
- GC49424Pyridostigmine-d3 (bromide)纯度: >99.00%
An internal standard for the quantification of pyridostigmine
- GC49532S-(1,2-Dichlorovinyl)-Cysteine (hydrochloride)CAS: 2508026-62-6纯度: >95.00%
A nephrotoxin and metabolite of trichloroethylene
- GC49590Docosahexaenoic Acid 1,2,3,4-13C纯度: >95.00%
An internal standard for the quantification of DHA
- GC49856Choline-d9 (chloride)CAS: 61037-86-3纯度: >99.00%
An internal standard for the quantification of choline
- GC520566(Z),9(Z),12(Z),15(Z)-Hexadecatetraenoic Acid ethyl esterCAS: 845779-89-7纯度: >98.00%
A polyunsaturated fatty ester
- GC5207110-oxo-12(Z)-Octadecenoic AcidCAS: 103521-29-5纯度: >95.00%
A metabolite of linoleic acid and an activator of TRPV1
- GC52278Creatine Phosphate (sodium salt hydrate)CAS: 19333-65-4纯度: >95.00%
A phosphorylated form of creatine
- GC52281Losartan AzideCAS: 727718-93-6纯度: >95.00%
A potential impurity in commercial preparations of losartan
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49389 | Tritylolmesartan Medoxomil | 144690-92-6 | >98.00% | |
An intermediate in the synthesis of olmesartan medoxomil | ||||
| GC49406 | ACT-373898 | 1433875-14-9 | >90.00% | |
A metabolite of macitentan | ||||
| GC49413 | Rizatriptan N-oxide | 260435-42-5 | >90.00% | |
A potential impurity found in commercial preparations of rizatriptan | ||||
| GC49424 | Pyridostigmine-d3 (bromide) | - | >99.00% | |
An internal standard for the quantification of pyridostigmine | ||||
| GC49426 | Taurine-d4 | 342611-14-7 | >99.00% | |
An internal standard for the quantification of taurine | ||||
| GC49435 | rac-1,2-bis-Palmitoyl-3-chloropropanediol | 51930-97-3 | >95.00% | |
A 3-MCPD ester | ||||
| GC49463 | IPG-2 AM | 1369302-24-8 | >90.00% | |
A cell-permeable fluorescent potassium indicator | ||||
| GC49473 | ARA 290 (acetate) | - | >95.00% | |
A derivative of EPO | ||||
| GC49516 | Dopamine 4-O-Sulfate | 38339-02-5 | >95.00% | |
An inactive metabolite of dopamine | ||||
| GC49518 | Fluindione | 957-56-2 | >98.00% | |
A vitamin K antagonist | ||||
| GC49532 | S-(1,2-Dichlorovinyl)-Cysteine (hydrochloride) | 2508026-62-6 | >95.00% | |
A nephrotoxin and metabolite of trichloroethylene | ||||
| GC49560 | L6H21 | 24533-47-9 | >98.00% | |
An inhibitor of the MD-2 and TLR4 interaction | ||||
| GC49566 | DX600 (trifluoroacetate salt) | - | >98.00% | |
A peptide inhibitor of ACE2 | ||||
| GC49590 | Docosahexaenoic Acid 1,2,3,4-13C | - | >95.00% | |
An internal standard for the quantification of DHA | ||||
| GC49620 | GSK 417651A | 736945-96-3 | >98.00% | |
A TRPC3 and TRPC6 inhibitor | ||||
| GC49781 | Benomyl | 17804-35-2 | >95.00% | |
A carbamate pesticide | ||||
| GC49856 | Choline-d9 (chloride) | 61037-86-3 | >99.00% | |
An internal standard for the quantification of choline | ||||
| GC49866 | Desmethyl Carvedilol | 72956-44-6 | >90.00% | |
An active metabolite of carvedilol | ||||
| GC52005 | Triazolomethylindole-3-acetic Acid | 177270-91-6 | >95.00% | |
A metabolite of rizatriptan | ||||
| GC52056 | 6(Z),9(Z),12(Z),15(Z)-Hexadecatetraenoic Acid ethyl ester | 845779-89-7 | >98.00% | |
A polyunsaturated fatty ester | ||||
| GC52071 | 10-oxo-12(Z)-Octadecenoic Acid | 103521-29-5 | >95.00% | |
A metabolite of linoleic acid and an activator of TRPV1 | ||||
| GC52106 | 5-hydroxy Isatin | 116569-09-6 | >98.00% | |
An inhibitor of MAO-A | ||||
| GC52278 | Creatine Phosphate (sodium salt hydrate) | 19333-65-4 | >95.00% | |
A phosphorylated form of creatine | ||||
| GC52281 | Losartan Azide | 727718-93-6 | >95.00% | |
A potential impurity in commercial preparations of losartan | ||||
